(Q34588247)

English

The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

The combination of ribavirin and peginterferon is superior to peginterferon and placebo for children and adolescents with chronic hepatitis C. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

17

object named as

Bruce A Barton

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Jean P. Molleston

4

object named as

Jean P Molleston

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

author name string

Kathleen B Schwarz

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Regino P Gonzalez-Peralta

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Karen F Murray

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Barbara A Haber

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Maureen M Jonas

6

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Philip Rosenthal

7

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Parvathi Mohan

8

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

William F Balistreri

9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Michael R Narkewicz

10

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Lesley Smith

11

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Steven J Lobritto

12

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Stephen Rossi

13

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Alexandra Valsamakis

14

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Zachary Goodman

15

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Patricia R Robuck

16

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Peds-C Clinical Research Network

18

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

language of work or name

0 references

publication date

28 October 2010

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

140

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

450-458.e1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Mechanism of action of ribavirin in the treatment of chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

7 July 2018

Ophthalmologic complications in children with chronic hepatitis C treated with pegylated interferon

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

7 July 2018

High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

7 July 2018

Diagnosis, management, and treatment of hepatitis C: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

7 July 2018

Impact of Hepatitis C Virus Infection on Children and Their Caregivers: Quality of Life, Cognitive, and Emotional Outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

7 July 2018

Assessing ribavirin exposure during pregnancy: the Ribavirin Pregnancy Registry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

7 July 2018

Efficacy and safety of peginterferon-alpha2b and ribavirin combination therapy in children with chronic hepatitis C infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

7 July 2018

Pathology of chronic hepatitis C in children: liver biopsy findings in the Peds-C Trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

7 July 2018

Design of the PEDS-C trial: pegylated interferon +/- ribavirin for children with chronic hepatitis C viral infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

7 July 2018

Peginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

7 July 2018

Optimal therapy of hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

7 July 2018

Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

7 July 2018

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

7 July 2018

An analysis of published trials of interferon monotherapy in children with chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

7 July 2018

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

7 July 2018

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

7 July 2018

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

7 July 2018

Teratogenic effects of ribavirin on hamster and rat embryos

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

7 July 2018

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

27 October 2018

Pegylated interferon and ribavirin-induced depression in chronic hepatitis C: role of personality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

27 October 2018

Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

27 October 2018

Safety, efficacy and pharmacokinetics of peginterferon alpha2a (40 kd) in children with chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

27 October 2018

The natural history of hepatitis C virus in pediatric liver transplant recipients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

27 October 2018

The burden of hepatitis C virus infection in children: estimated direct medical costs over a 10-year period

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

27 October 2018

Liver histology and alanine aminotransferase levels in children and adults with chronic hepatitis C infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

27 October 2018

Interferon alfa-2b in combination with ribavirin for the treatment of chronic hepatitis C in children: efficacy, safety, and pharmacokinetics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

27 October 2018

Three broad modalities in the natural history of vertically acquired hepatitis C virus infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

27 October 2018

Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

27 October 2018

Embryotoxic, teratogenic, and metabolic effects of ribavirin in mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3042126

27 October 2018

Understanding social stigma in women with hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/21036173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatocellular carcinoma in 2 young adolescents with chronic hepatitis C

1 reference

https://pubmed.ncbi.nlm.nih.gov/21036173

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1053/J.GASTRO.2010.10.047

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34588247&oldid=1959054380"